dQ&A, the leader in diabetes market research, announced the beta release of its new AI-powered diabetes insights platform: a natural-language decision tool that quickly answers a wide range of diabetes business questions, using dQ&A's expansive database of primary research.

"Working with AI experts, we're creating a 'killer app' for diabetes research," said Richard Wood, CEO of dQ&A. "Our new solution should dramatically reduce decision-making time for business leaders – unlocking the insights of big data, without any of the friction. Suddenly, the answers are at your fingertips."

Opening Up Insights

The new platform allows users to ask complex business and research questions in plain English. It interprets a user's question, identifies and analyzes the relevant data points, and quickly creates visualizations ready to drop into reports or presentations.

dQ&A achieves this by querying its proprietary 'data lake' of diabetes knowledge - containing millions of responses from tens of thousands of patients and prescribers, across dozens of products, in nine countries, compiled over 15 years. The data is longitudinal, representative and reliable, and forms the basis for dQ&A's successful range of diabetes Data Services products.

Built thoughtfully, the new AI-based platform accesses this knowledge, eliminating the steps of data analysis and presentation, and opening up insights for all.

Timeframe for Availability

"I'm so excited to launch our beta program," said Christianne Pang, VP of Product at dQ&A. "We've been working hard behind the scenes to deliver a robust, intuitive solution. Now it's time for real-world testing — and we expect the productivity gains to be immediately noticeable."

dQ&A will invite selected Data Services clients to participate in the beta program over the coming weeks, ahead of broader availability. The new platform is expected to launch formally in early 2026.